Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pharmaceutical Biotechnology
  4. Fast Track Articles
  5. Fast Track Article
image of Role of Medicinal Plants in the Management of Multiple Sclerosis

Abstract

There is a rapid spread of Multiple Sclerosis disorder across the globe, around 2.8 million cases of Multiple Sclerosis in the world. Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system characterized by demyelination, neuroinflammation, and a wide spectrum of clinical manifestations. Many drugs have been tested on MS patients but there is no effective treatment for MS till now. So to inhibit the symptoms caused by MS we performed a study in which we identified various naturally occurring materials with neuroprotective effects on the body that can treat Multiple Sclerosis. The therapeutic strategies portion of the paper reviews the array of disease-modifying therapies currently available for MS management. This paper evaluated their mechanisms of action, efficacy, and safety profiles. It also addressed emerging treatment paradigms by using different naturally occurring materials, including personalized medicine approaches and novel therapies in development. This paper provides a comprehensive overview of the current state of knowledge regarding MS, focusing on its pathogenesis, diagnostic approaches, and therapeutic strategies.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpb/10.2174/0113892010324850240923181408
2024-10-10
2024-11-20

  • From This Site

    /content/journals/cpb/10.2174/0113892010324850240923181408
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Feinstein A. The neuropsychiatry of multiple sclerosis. Can. J. Psychiatry 2004 49 3 157 163 10.1177/070674370404900302 15101497
    [Google Scholar]
  2. Dobson R. Giovannoni G. Multiple sclerosis – A review. Eur. J. Neurol. 2019 26 1 27 40 10.1111/ene.13819 30300457
    [Google Scholar]
  3. Goldenberg M.M. Multiple sclerosis review. P&T 2012 37 3 175 184 22605909
    [Google Scholar]
  4. Ebers G.C. Environmental factors and multiple sclerosis. Lancet Neurol. 2008 7 3 268 277 10.1016/S1474‑4422(08)70042‑5 18275928
    [Google Scholar]
  5. Luthra R. Roy A. Role of medicinal plants against neurodegenerative diseases. Curr. Pharm. Biotechnol. 2022 23 1 123 139 10.2174/1389201022666210211123539 33573549
    [Google Scholar]
  6. Murray T.J. Diagnosis and treatment of multiple sclerosis. BMJ 2006 332 7540 525 527 10.1136/bmj.332.7540.525 16513709
    [Google Scholar]
  7. Hauser S.L. Cree B.A.C. Treatment of multiple sclerosis: A review. Am. J. Med. 2020 133 12 1380 1390.e2 10.1016/j.amjmed.2020.05.049 32682869
    [Google Scholar]
  8. Mojaverrostami S. Bojnordi M.N. Ghasemi-Kasman M. Ebrahimzadeh M.A. Hamidabadi H.G. A review of herbal therapy in multiple sclerosis. Adv. Pharm. Bull. 2018 8 4 575 590 10.15171/apb.2018.066 30607330
    [Google Scholar]
  9. Olsen S.A. A review of complementary and alternative medicine (CAM) by people with multiple sclerosis. Occup. Ther. Int. 2009 16 1 57 70 10.1002/oti.266 19222053
    [Google Scholar]
  10. Shamsizadeh A. Roohbakhsh A. Ayoobi F. Moghaddamahmadi A. The role of natural products in the prevention and treatment of multiple sclerosis. Nutrition and lifestyle in neurological autoimmune diseases. Academic Press 2017 249 260 10.1016/B978‑0‑12‑805298‑3.00025‑6
    [Google Scholar]
  11. Küçükkurt İ. Akbel E. İnce S. Acaröz D.A. Demirel H.H. Kan F. Potential protective effect of escin from Aesculus hippocastanum extract against cyclophosphamide-induced oxidative stress on rat tissues. Toxicol. Res. 2022 11 5 812 818 10.1093/toxres/tfac059 36337244
    [Google Scholar]
  12. Farzaei M.H. Shahpiri Z. Bahramsoltani R. nia M.M. Najafi F. Rahimi R. Efficacy and tolerability of phytomedicines in multiple sclerosis patients: A review. CNS Drugs 2017 31 10 867 889 10.1007/s40263‑017‑0466‑4 28948486
    [Google Scholar]
  13. Loría Gutiérrez A. Blanco Barrantes J. Porras Navarro M. Ortega Monge MC. Cerdas Vargas MJ. Madrigal Redondo GL. General aspects about Allium sativum–a review. Ars Pharmaceutica 2021 1 4 62 10.30827/ars.v62i4.20843
    [Google Scholar]
  14. Elkhawas Y.A. Seleem M. Shabayek M.I. Majrashi T.A. Al-Warhi T. Eldehna W.M. Mostafa N.M. Phytochemical profiling and mechanistic evaluation of black garlic extract on multiple sclerosis rat model. J. Funct. Foods 2023 111 105900 10.1016/j.jff.2023.105900
    [Google Scholar]
  15. Ekiert H. Świątkowska J. Knut E. Klin P. Rzepiela A. Tomczyk M. Szopa A. Artemisia dracunculus (Tarragon): A review of its traditional uses, phytochemistry, and pharmacology. Front. Pharmacol. 2021 12 653993 10.3389/fphar.2021.653993 33927629
    [Google Scholar]
  16. Dhiman A. Goyal J. Sharma K. Nanda A. Dhiman S. A review on medicinal prospectives of Andrographis paniculata Nees. J Pharm Sci Innov. 2012 1 1
    [Google Scholar]
  17. Safari H. Anani Sarab G. Naseri M. Artemisia dracunculus L. modulates the immune system in a multiple sclerosis mouse model. Nutr. Neurosci. 2021 24 11 843 849 10.1080/1028415X.2019.1681742 31665978
    [Google Scholar]
  18. Song JY. Meng LQ. Li XM. Therapeutic application and prospect of Astragalus membranaceus and Angelica sinensis in treating renal microvascular lesions. Chin. J. Integr. Trad. West. Med. 2008 28 9 859 861
    [Google Scholar]
  19. Bertoglio J.C. Baumgartner M. Palma R. Ciampi E. Carcamo C. Cáceres D.D. Acosta-Jamett G. Hancke J.L. Burgos R.A. Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: A 12-month double-blind placebo-controlled pilot study. BMC Neurol. 2016 16 1 77 10.1186/s12883‑016‑0595‑2 27215274
    [Google Scholar]
  20. Banerjee S. Anand U. Ghosh S. Ray D. Ray P. Nandy S. Deshmukh G.D. Tripathi V. Dey A. Bacosides from Bacopa monnieri extract: An overview of the effects on neurological disorders. Phytother. Res. 2021 35 10 5668 5679 10.1002/ptr.7203 34254371
    [Google Scholar]
  21. Gupta A. Roy A. Raja V. Rustagi S. Malik S. Verma D. In-silico studies of phytoconstituents of bacopa monnieri and centella asiatica with crystal structure of myelin oligodendrocyte glycoprotein against primary demyelination in multiple sclerosis. J Integr Sci Technol. 2024 12 3 764 10.62110/sciencein.jist.2024.v12.764
    [Google Scholar]
  22. Imenshahidi M. Hosseinzadeh H. Berberis vulgaris and berberine: An update review. Phytother. Res. 2016 30 11 1745 1764 10.1002/ptr.5693 27528198
    [Google Scholar]
  23. Fragoso Y.D. Carra A. Macias M.A. Cannabis and multiple sclerosis. Expert Rev. Neurother. 2020 20 8 849 854 10.1080/14737175.2020.1776610 32515670
    [Google Scholar]
  24. Roy A. Gupta A. Verma D. Evaluation of different phytochemicals from Cannabis sativa against Myelin oligodendrocyte glycoprotein receptor. Vegetos 2023 10.1007/s42535‑023‑00753‑8
    [Google Scholar]
  25. Kandikattu H.K. Amruta N. Khanum F. Narayana V.V.P.C. Srinivasulu D. Phytochemical composition, pharmacological properties, and therapeutic applications of celastrus paniculatus. Curr. Tradit. Med. 2021 7 1 107 124 10.2174/2215083806666200218111155
    [Google Scholar]
  26. Gray N.E. Alcazar Magana A. Lak P. Wright K.M. Quinn J. Stevens J.F. Maier C.S. Soumyanath A. Centella asiatica: Phytochemistry and mechanisms of neuroprotection and cognitive enhancement. Phytochem. Rev. 2018 17 1 161 194 10.1007/s11101‑017‑9528‑y 31736679
    [Google Scholar]
  27. Asadi Z. Ghazanfari T. Hatami H. Anti-inflammatory effects of Matricaria chamomilla extracts on BALB/c mice macrophages and lymphocytes. Iran. J. Allergy Asthma Immunol. 2020 19 S1 63 73 10.18502/ijaai.v19i(s1.r1).2862 32534512
    [Google Scholar]
  28. Grammatikopoulou M.G. Tsiogkas S.G. Gkiouras K. Gioxari A. Daskalou E. Maraki M.I. Dardiotis E. Bogdanos D.P. Supplementation with Crocus sativus L. (Saffron) against placebo in multiple sclerosis: A systematic review and synthesis without meta-analysis of randomized controlled trials. Dietetics 2022 1 3 227 241 10.3390/dietetics1030020
    [Google Scholar]
  29. Rehman S. Ray A. Neuroprotective medicinal plants: Focus on curcuma longa. EC Pharmacology and Toxicology. 2020 8 16 30
    [Google Scholar]
  30. Zarshenas M.M. Ansari R. Dadbakhsh A. Mohammadi M. A review of herbal remedies for multiple sclerosis-like disorders in traditional persian medicine (TPM). Curr. Drug Metab. 2018 19 5 392 407 10.2174/1389200219666180305152057 29512456
    [Google Scholar]
  31. Ajuwon O.R. Marnewick J.L. Improved modulation of the endogenous antioxidant system and inflammatory responses in male wistar rats by rooibos (Aspalathus linearis) and red palm oil (Elaeis guineensis). Doctoral dissertation, Cape Peninsula University of Technology 2012
    [Google Scholar]
  32. Sun Y. Zhang Z. Cheng L. Zhang X. Liu Y. Zhang R. Weng P. Wu Z. Polysaccharides confer benefits in immune regulation and multiple sclerosis by interacting with gut microbiota. Food Res. Int. 2021 149 110675 10.1016/j.foodres.2021.110675 34600677
    [Google Scholar]
  33. Gupta A. Roy A. Pandit S. Pandey N. Rustagi S. Evaluation of bioactive compounds obtained from ginkgo biloba against crystal structure of myelin oligodendrocyte glycoprotein (MOG). OBM Neurobiol. 2023 7 4 1 34 10.21926/obm.neurobiol.2304186
    [Google Scholar]
  34. Bayram C. Hacimuftuoglu A. Investigation of antioxidant efficacy of glycyrrhiza glabra l. extract in glutamate toxicity-induced primary neuron culture. Anatolian Journal of Biology. 2022 3 1 18 24
    [Google Scholar]
  35. Ahmad I. Dhar D. Rao J.S. Swaroop A. Ahmad T. Bagchi D. Development of a Synergistic Combination of Huperzia serrata, Convolvulus pluricaulis, and Celastrus paniculatus for Optimal Brain Health and Functions. InAntioxidants and Functional Foods for Neurodegenerative Disorders. CRC Press 2021 329 353
    [Google Scholar]
  36. Afsharzadeh N. Lavi Arab F. Sankian M. Samiei L. Tabasi N.S. Afsharzadeh D. Nikkhah K. Mahmoudi M. Comparative assessment of proliferation and immunomodulatory potential of Hypericum perforatum plant and callus extracts on mesenchymal stem cells derived adipose tissue from multiple sclerosis patients. Inflammopharmacology 2021 29 5 1399 1412 10.1007/s10787‑021‑00838‑3 34510276
    [Google Scholar]
  37. Zha Z. Liu S. Liu Y. Li C. Wang L. Potential utility of natural products against oxidative stress in animal models of multiple sclerosis. Antioxidants 2022 11 8 1495 10.3390/antiox11081495 36009214
    [Google Scholar]
  38. Schmitz K. Barthelmes J. Stolz L. Beyer S. Diehl O. Tegeder I. “Disease modifying nutricals” for multiple sclerosis. Pharmacol. Ther. 2015 148 85 113 10.1016/j.pharmthera.2014.11.015 25435020
    [Google Scholar]
  39. Rabiei Z. Phytotherapy as a complementary medicine for multiple sclerosis. Turk. J. Pharm. Sci. 2019 16 2 246 10.4274/tjps.galenos.2018.90522
    [Google Scholar]
  40. Mahboubi M. Taghizadeh M. Talaei S.A. Takht Firozeh S.M. Rashidi A.A. Tamtaji O.R. Combined administration of Melissa officinalis and Boswellia serrata extracts in an animal model of memory. Iran. J. Psychiatry. Behav. Sci. 2016 10 3 e681 10.17795/ijpbs‑681 27822272
    [Google Scholar]
  41. Kim I.T. Park H.J. Nam J.H. Park Y.M. Won J.H. Choi J. Choe B.K. Lee K.T. In-vitro and in-vivo anti-inflammatory and antinociceptive effects of the methanol extract of the roots of Morinda officinalis. J. Pharm. Pharmacol. 2010 57 5 607 615 10.1211/0022357055902 15901350
    [Google Scholar]
  42. Alam MZ A review on Plant based remedies for the treatment of Multiple Sclerosis. InAnnales Pharmaceutiques Françaises Elsevier Masson 2023 10.1016/j.pharma.2023.03.005
    [Google Scholar]
  43. Chen H. Ma X. Si L. Chen Z. Lin X. Yang Y. Chen X. Traditional Chinese Medicine in multiple sclerosis: Theory and practice. Curr. Pharmacol. Rep. 2018 4 6 436 446 10.1007/s40495‑018‑0158‑x
    [Google Scholar]
  44. Bayat P. Farshchi M. Yousefian M. Mahmoudi M. Yazdian-Robati R. Flavonoids, the compounds with anti-inflammatory and immunomodulatory properties, as promising tools in multiple sclerosis (MS) therapy: A systematic review of preclinical evidence. Int. Immunopharmacol. 2021 95 107562 10.1016/j.intimp.2021.107562 33770729
    [Google Scholar]
  45. Abdelhalim A. Hanrahan J. Biologically active compounds from Lamiaceae family: Central nervous system effects. Studies in Natural Products Chemistry 2021 68 255 315 10.1016/B978‑0‑12‑819485‑0.00017‑7
    [Google Scholar]
  46. Prakash R.S. Snook E.M. Motl R.W. Kramer A.F. Aerobic fitness is associated with gray matter volume and white matter integrity in multiple sclerosis. Brain Res. 2010 1341 41 51 10.1016/j.brainres.2009.06.063 19560443
    [Google Scholar]
  47. Cock I.E. Cheesman M.J. The early stages of multiple sclerosis: New targets for the development of combinational drug therapies. Engineering and clinical perspectives of multiple sclerosis. Neurological Disorders and Imaging Physics 2 Bristol, UK IOP Publishing 2019 2 1
    [Google Scholar]
  48. Antioch I. Ciobica A. Compaore M. Hilou A. Kiendrebeogo M. Foyet H. Guenné S. Phytotherapeutical implications in pain perception - Focusing on schizophrenia. Int. J. Phytomed. 2017 9 2 167 180 10.5138/09750185.1891
    [Google Scholar]
  49. Yong J. Breakdown of the blood-brain barrier, brain insulin resistance, and an accumulation in dementia caused by diabetes. J. Mult. Scler. 2002 9 06 001 002
    [Google Scholar]
  50. Cha D.S. Jeon H. Anti-inflammatory effect of MeOH extracts of the stem of Polygonum multiflorum in LPS-stimulated mouse peritoneal macrophages. Nat. Prod. Sci. 2009 15 2 83 89
    [Google Scholar]
  51. Moyer J.H. Beazley H.L. McConn R. Hughes W. Ford R. Dennis E. Clinical results with the use of Roxinil (an extract of Rauwolfia serpentina) in the treatment of hypertension. Am. Heart J. 1955 49 5 751 757 10.1016/0002‑8703(55)90220‑9 14376328
    [Google Scholar]
  52. Pu W. Zhang M. Bai R. Sun L. Li W. Yu Y. Zhang Y. Song L. Wang Z. Peng Y. Shi H. Zhou K. Li T. Anti-inflammatory effects of Rhodiola rosea L.: A review. Biomed. Pharmacother. 2020 121 109552 10.1016/j.biopha.2019.109552 31715370
    [Google Scholar]
  53. Ramachandran C. Quirin K.W. Escalon E. Melnick S.J. Improved neuroprotective effects by combining Bacopa monnieri and Rosmarinus officinalis supercritical CO2 extracts. J. Evid. Based Complementary Altern. Med. 2014 19 2 119 127 10.1177/2156587214524577 24647092
    [Google Scholar]
  54. Singh L. Yasmin S. Sharma R. Current approaches for the management of multiple sclerosis – A review. J. Pharm. Res. Int. 2021 33 52B 222 228 10.9734/jpri/2021/v33i52B33620
    [Google Scholar]
  55. Łedo A. Quaternary benzo [c] phenanthridine alkaloids as inhibitors of dipeptidyl peptidase IV-like activity bearing enzymes in human blood plasma and glioma cell lines. Physiol. Res. 2003 52 367 372 12790770
    [Google Scholar]
  56. Sowndhararajan K. Deepa P. Kim M. Park S.J. Kim S. An overview of neuroprotective and cognitive enhancement properties of lignans from Schisandra chinensis. Biomed. Pharmacother. 2018 97 958 968 10.1016/j.biopha.2017.10.145 29136774
    [Google Scholar]
  57. Faraji F. Hashemi M. Ghiasabadi A. Davoudian S. Talaie A. Ganji A. Mosayebi G. Combination therapy with interferon beta-1a and sesame oil in multiple sclerosis. Complement. Ther. Med. 2019 45 275 279 10.1016/j.ctim.2019.04.010 31331574
    [Google Scholar]
  58. Bahrami M. Mosayebi G. Ghazavi A. Ganji A. Immunomodulation in multiple sclerosis by phytotherapy. Curr. Immunol. Rev. 2020 16 1 28 36 10.2174/1573395516999200930122850
    [Google Scholar]
  59. Dal Monte M. Cammalleri M. Locri F. Amato R. Marsili S. Rusciano D. Bagnoli P. Fatty acids dietary supplements exert anti-inflammatory action and limit ganglion cell degeneration in the retina of the EAE mouse model of multiple sclerosis. Nutrients 2018 10 3 325 10.3390/nu10030325 29517994
    [Google Scholar]
  60. Sundriyal A. Mukhija M. Phytoconstituents responsible for anti-inflammatory activity. J Nat Pharm. 2013 4 1 1 10.4103/2229‑5119.110340
    [Google Scholar]
  61. Glickman-Simon R. Mukherji A. Moxibustion for asthma, acupuncture for epilepsy, psychological therapies for irritable bowel syndrome, exercise training for multiple sclerosis, and comfrey root for acute back pain. Explore (NY) 2015 11 1 67 71 10.1016/j.explore.2014.10.010 25435497
    [Google Scholar]
  62. Rahimi V.B. Askari V.R. Shirazinia R. Soheili-Far S. Askari N. Rahmanian-Devin P. Sanei-Far Z. Mousavi S.H. Ghodsi R. Protective effects of hydro-ethanolic extract of Terminalia chebula on primary microglia cells and their polarization (M1/M2 balance). Mult. Scler. Relat. Disord. 2018 25 5 13 10.1016/j.msard.2018.07.015 30014878
    [Google Scholar]
  63. Kamal F.Z. Lefter R. Mihai C.T. Farah H. Ciobica A. Ali A. Radu I. Mavroudis I. Ech-Chahad A. Chemical composition, antioxidant and antiproliferative activities of Taraxacum officinale essential oil. Molecules 2022 27 19 6477 10.3390/molecules27196477 36235013
    [Google Scholar]
  64. Fintelmann V. Intuitive Medizin. Stuttgart Hippokrates 1995
    [Google Scholar]
  65. Trovato A. Pennisi M. Crupi R. Di Paola R. Alario A. Modafferi S. Di Rosa G. Fernandes T. Signorile A. Maiolino L. Cuzzocrea S. Neuroinflammation and mitochondrial dysfunction in the pathogenesis of Alzheimer’s disease: modulation by coriolus versicolor (Yun-Zhi) nutritional mushroom. J. Neurol. Neuromedicine 2017 2 1
    [Google Scholar]
  66. Soldan S.S. Retuerto A.I.A. Sicotte N.L. Voskuhl R.R. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J. Immunol. 2003 171 11 6267 6274 10.4049/jimmunol.171.11.6267 14634144
    [Google Scholar]
  67. Li J. Hao J. Treatment of neurodegenerative diseases with bioactive components of Tripterygium wilfordii. Am. J. Chin. Med. 2019 47 4 769 785 10.1142/S0192415X1950040X 31091976
    [Google Scholar]
  68. Pilarski R. Zieliński H. Ciesiołka D. Gulewicz K. Antioxidant activity of ethanolic and aqueous extracts of Uncaria tomentosa (Willd.) DC. J. Ethnopharmacol. 2006 104 1-2 18 23 10.1016/j.jep.2005.08.046 16202551
    [Google Scholar]
  69. Gallien P. Amarenco G. Benoit N. Bonniaud V. Donzé C. Kerdraon J. de Seze M. Denys P. Renault A. Naudet F. Reymann J.M. Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: A multicenter, randomized, placebo-controlled, double-blind trial. Mult. Scler. 2014 20 9 1252 1259 10.1177/1352458513517592 24402038
    [Google Scholar]
  70. Laplaud P.M. Lelubre A. Chapman M.J. Antioxidant action of Vaccinium myrtillus extract on human low density lipoproteins in vitro: Initial observations. Fundam. Clin. Pharmacol. 1997 11 1 35 40 10.1111/j.1472‑8206.1997.tb00166.x 9182074
    [Google Scholar]
  71. Williamson E. Synergy and other interactions in phytomedicines. Phytomedicine 2001 8 5 401 409 10.1078/0944‑7113‑00060 11695885
    [Google Scholar]
  72. Janakat S. Al-Thnaibat O. Antilipoperoxidative effect of three edible plants extracts: Viscum album, Arum dioscoridis and Eminium spiculatum. J. Food Qual. 2008 31 1 1 12 10.1111/j.1745‑4557.2007.00180.x
    [Google Scholar]
  73. Maker-Clark G. Patel S. Integrative therapies for multiple sclerosis. Dis. Mon. 2013 59 8 290 301 10.1016/j.disamonth.2013.03.017 23876486
    [Google Scholar]
  74. Kataria H. Wadhwa R. Kaul S.C. Kaur G. Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity. PLoS One 2012 7 5 e37080 10.1371/journal.pone.0037080 22606332
    [Google Scholar]
  75. Arcusa R. Villaño D. Marhuenda J. Cano M. Cerdà B. Zafrilla P. Potential role of ginger (Zingiber officinale Roscoe) in the prevention of neurodegenerative diseases. Front. Nutr. 2022 9 809621 10.3389/fnut.2022.809621 35369082
    [Google Scholar]
  76. Tovar R.T. Petzel R.M. Herbal toxicity. Dis. Mon. 2009 55 10 592 641 10.1016/j.disamonth.2009.05.001 19782820
    [Google Scholar]
  77. Bateman J. Chapman R.D. Simpson D. Possible toxicity of herbal remedies. Scott. Med. J. 1998 43 1 7 15 10.1177/003693309804300104 9533252
    [Google Scholar]
  78. Saxe T.G. Toxicity of medicinal herbal preparations. Am. Fam. Physician 1987 35 5 135 142 3577986
    [Google Scholar]
  79. Nasri H. Shirzad H. Toxicity and safety of medicinal plants. J HerbMed Plarmacol. 2013 2 2 21 22
    [Google Scholar]
  80. Rahman M.H. Bajgai J. Fadriquela A. Sharma S. Trinh T.T. Akter R. Jeong Y.J. Goh S.H. Kim C.S. Lee K.J. Therapeutic potential of natural products in treating neurodegenerative disorders and their future prospects and challenges. Molecules 2021 26 17 5327 10.3390/molecules26175327 34500759
    [Google Scholar]
  81. Di Paolo M. Papi L. Gori F. Turillazzi E. Natural products in neurodegenerative diseases: A great promise but an ethical challenge. Int. J. Mol. Sci. 2019 20 20 5170 10.3390/ijms20205170 31635296
    [Google Scholar]
  82. Shirani A. Okuda D.T. Stüve O. Therapeutic advances and future prospects in progressive forms of multiple sclerosis. Neurotherapeutics 2016 13 1 58 69 10.1007/s13311‑015‑0409‑z 26729332
    [Google Scholar]
  83. Shamaa A. Abdallah A. Bahr M. Tookhy O. A review: Multiple sclerosis treatment: Current strategies and future hopes. Alex. J. Vet. Sci. 2020 66 2 30 10.5455/ajvs.125962
    [Google Scholar]
  84. Sapko K. Jamroz-Wiśniewska A. Rejdak K. Novel drugs in a pipeline for progressive multiple sclerosis. J. Clin. Med. 2022 11 12 3342 10.3390/jcm11123342 35743410
    [Google Scholar]
  85. Shah Z. Wasay M. Chaudhry B.Z. Fredrikson S. Multiple sclerosis in Pakistan: Current status and future perspective. J. Neurol. Sci. 2020 418 117066 10.1016/j.jns.2020.117066 32823132
    [Google Scholar]
  86. Allanach J.R. Farrell J.W. III Mésidor M. Karimi-Abdolrezaee S. Current status of neuroprotective and neuroregenerative strategies in multiple sclerosis: A systematic review. Mult. Scler. 2022 28 1 29 48 10.1177/13524585211008760 33870797
    [Google Scholar]
  87. Misiak B. Samochowiec J. Kowalski K. Gaebel W. Bassetti C.L.A. Chan A. Gorwood P. Papiol S. Dom G. Volpe U. Szulc A. Kurimay T. Kärkkäinen H. Decraene A. Wisse J. Fiorillo A. Falkai P. The future of diagnosis in clinical neurosciences: Comparing multiple sclerosis and schizophrenia. Eur. Psychiatry 2023 66 1 e58 10.1192/j.eurpsy.2023.2432 37476977
    [Google Scholar]
  88. Zahoor I. Giri S. Specialized pro-resolving lipid mediators: Emerging therapeutic candidates for multiple sclerosis. Clin. Rev. Allergy Immunol. 2021 60 2 147 163 10.1007/s12016‑020‑08796‑4 32495237
    [Google Scholar]
  89. Park S.J. Choi J.W. Brain energy metabolism and multiple sclerosis: Progress and prospects. Arch. Pharm. Res. 2020 43 10 1017 1030 10.1007/s12272‑020‑01278‑3 33119885
    [Google Scholar]
  90. Celius E.G. Thompson H. Pontaga M. Langdon D. Laroni A. Potra S. Bharadia T. Yeandle D. Shanahan J. van Galen P. Alexandri N. Kesselring J. Disease progression in multiple sclerosis: A literature review exploring patient perspectives. Patient Prefer. Adherence 2021 15 15 27 10.2147/PPA.S268829 33447018
    [Google Scholar]
  91. Papiri G. D’Andreamatteo G. Cacchiò G. Alia S. Silvestrini M. Paci C. Luzzi S. Vignini A. Multiple sclerosis: Inflammatory and neuroglial aspects. Curr. Issues Mol. Biol. 2023 45 2 1443 1470 10.3390/cimb45020094 36826039
    [Google Scholar]
  92. Wei W. Ma D. Li L. Zhang L. Progress in the application of drugs for the treatment of multiple sclerosis. Front. Pharmacol. 2021 12 724718 10.3389/fphar.2021.724718 34326775
    [Google Scholar]
  93. Lubetzki C. Zalc B. Williams A. Stadelmann C. Stankoff B. Remyelination in multiple sclerosis: From basic science to clinical translation. Lancet Neurol. 2020 19 8 678 688 10.1016/S1474‑4422(20)30140‑X 32702337
    [Google Scholar]
  94. Cunniffe N. Coles A. Promoting remyelination in multiple sclerosis. J. Neurol. 2021 268 1 30 44 10.1007/s00415‑019‑09421‑x 31190170
    [Google Scholar]
  95. Zahoor I. Rui B. Khan J. Datta I. Giri S. An emerging potential of metabolomics in multiple sclerosis: A comprehensive overview. Cell. Mol. Life Sci. 2021 78 7 3181 3203 10.1007/s00018‑020‑03733‑2 33449145
    [Google Scholar]
  96. Gupta A. Roy A. Kaur K. Rustagi S. Malik S. Pandit S. Scope of nanomaterials in treating neurological disorders. OBM Neurobiol. 2024 8 1 1 22 10.21926/obm.neurobiol.2401208
    [Google Scholar]
/content/journals/cpb/10.2174/0113892010324850240923181408
Loading
Role of Medicinal Plants in the Management of Multiple Sclerosis
Bentham Science Publishers ; https://doi.org/10.2174/0113892010324850240923181408
/content/journals/cpb/10.2174/0113892010324850240923181408
/content/journals/cpb/10.2174/0113892010324850240923181408
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: diagnostic approaches ; herbal therapies ; Multiple sclerosis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test